Spinal Cord Injury
📧 Sign up to get email alerts when something new happens for Spinal Cord Injury.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-04Clinical Trial Update: NISCI - Nogo Inhibition in Spinal Cord Injury [Phase 2]
Phase 2 clinical trial update for NISCI investigating Nogo inhibition in acute spinal cord injury has completed.
-
CLINICAL_TRIALS trial_result · 2023-02-17Clinical Trial Update: Feasibility of Exercise and Spinal Cord Injury [NA]
Feasibility study related to exercise for spinal cord injury; completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-16Clinical Trial Update: Long Duration Activity and Metabolic Control After Spinal Cord Injury [NA]
A completed clinical trial on long duration activity and metabolic control after spinal cord injury; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-08Clinical Trial Update: Bowel Care and Cardiovascular Function After Spinal Cord Injury [Phase 4]
Phase 4 clinical trial update on bowel care and cardiovascular function after spinal cord injury; results completed with posted results.
-
CLINICAL_TRIALS trial_result · 2023-01-12Clinical Trial Update: Autologous Bone Marrow Stem Cell Transplantation in Patients With Subacute Spinal Cord Injury [Phase 2]
Phase 2 clinical trial update on autologous bone marrow stem cell transplantation for spinal cord injury.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-01-05Clinical Trial Update: Patterned Functional Electrical Stimulation (FES) Ergometry of Arm and Shoulder in Individuals With Spinal Cord Injury [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating patterned functional electrical stimulation (FES) ergometry of the arm and shoulder in individuals wit…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: Clinical Trial to Evaluate Safety, Tolerability and Efficacy of NFX88 in SCI [Phase 2]
Phase 2 trial evaluating safety, tolerability, and efficacy of NFX88 in neuropathic pain associated with spinal cord injuries has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Prevention of Bladder Dysfunction in Acute Spinal Cord Injury [Phase 4]
Phase 4 trial update on preventing bladder dysfunction after acute spinal cord injury.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Effects of CB1 Antagonist/Reverse Agonist Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury [Phase 2]
Phase 2 clinical trial evaluating the effects of a CB1 antagonist/reverse agonist (Rimonabant) on walking abilities in individuals with inco…
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Effects of Rimonabant on Walking Abilities in Incomplete Spinal Cord Injury [Phase 1, Phase 2]
Clinical trial investigating the effects of rimonabant on walking abilities in individuals with incomplete spinal cord injury has completed …
-
CLINICAL_TRIALS trial_result · 2022-11-15Clinical Trial Update: Active Powered Prosthesis (APEX) for Spinal Cord Injury [NA]
A completed clinical trial update for the Active Powered Prosthesis (APEX) in spinal cord injury; results were posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-11-04Clinical Trial Update: Musculoskeletal Plasticity After Spinal Cord Injury [NA]
A completed clinical trial investigating musculoskeletal plasticity after spinal cord injury; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-10-17Clinical Trial Update: Effects of 5HTP and LDOPA on CNS Excitability After SCI [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating effects of 5-HTP and L-DOPA on CNS excitability after spinal cord injury; the study is currently susp…
-
CLINICAL_TRIALS trial_result · 2022-10-14Clinical Trial Update: Ultrasound-Guided Treatments for Shoulder Pain in Wheelchair Users With Spinal Cord Injury [Phase 2]
A Phase 2 clinical trial evaluating ultrasound-guided treatments for shoulder pain in wheelchair users with spinal cord injury is ongoing or…
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Capsaicin 8% Patch for Spinal Cord Injury Neuropathic Pain [NA]
Completed clinical trial evaluating capsaicin 8% patch for spinal cord injury–related neuropathic pain; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-08-26Clinical Trial Update: Phase 3 Study of KP-100IT in Subjects With Acute Spinal Cord Injury [Phase 3]
Phase 3 clinical trial update for KP-100IT in acute spinal cord injury; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Effects of Caffeine and Intermittent Hypoxia on Leg Function in Human Spinal Cord Injury [Phase 1, Phase 2]
A completed phase 1/2 trial evaluating caffeine and intermittent hypoxia effects on leg function after spinal cord injury; results posted in…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Respiratory Capacity and Swallowing Function in Spinal Disorders: A Pilot Study
Pilot study evaluating respiratory capacity and swallowing function in spinal disorders; completed with posted results.
-
FDA approval · 2022-06-10FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
The FDA approved a supplemental application for a generic tizanidine hydrochloride product submitted by Alembic Pharmaceuticals Limited unde…
-
FDA approval · 2022-06-10FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Tizanidine Hydrochloride from Aurobindo Pharma Limited under an ANDA. This action confirms regul…
-
CLINICAL_TRIALS trial_result · 2022-06-07Clinical Trial Update: Spinal Cord Injury Neuroprotection With Glyburide [Phase 1, Phase 2]
Phase 1/2 trial investigating glyburide for neuroprotection in acute spinal cord injury; terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2022-06-06Clinical Trial Update: Powered Exoskeletons in Persons With SCI [NA]
A completed clinical trial evaluating powered exoskeletons for individuals with spinal cord injury, with results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2022-05-31Clinical Trial Update: Efficacy and Safety of Growth Hormone Treatment in Spinal Cord Injury [Phase 3]
Phase 3 trial assessing the efficacy and safety of growth hormone treatment in spinal cord injury has completed.
-
FDA approval · 2022-05-25FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approves a supplemental application for tizanidine hydrochloride submitted by Zydus Lifesciences Limited. This action completes FDA appr…
-
FDA approval · 2022-05-25FDA Approved: TIZANIDINE HYDROCHLORIDE — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
FDA approved a supplemental application for tizanidine hydrochloride by Nivagen Pharmaceuticals, Inc., representing a regulatory update for …